Skip to main content
Signal8

Slaoui Moncef

SEC insider (Form 3/4/5 filer). CIK 0001712369. Director at Vaxcyte, Inc. (PCVX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SAN DIEGO, CA.

Companies Slaoui Moncef has filed insider reports for

  • Vaxcyte, Inc. (PCVX): Director
  • Arcturus Therapeutics Holdings Inc. (ARCT): Director
Slaoui Moncef profile photo

Slaoui Moncef

CIK: 0001712369

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Vaxcyte, Inc. logo
PCVX

Vaxcyte, Inc.

Director
Arcturus Therapeutics Holdings Inc. logo
ARCT

Arcturus Therapeutics Holdings Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Jun 22, 2026
    Award

    Stock Option (right to buy)

    Direct
    26.1K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Jun 5, 2026
    Award

    Stock option (right to buy)

    Direct
    15K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Jun 9, 2025
    Award

    Stock option (right to buy)

    Direct
    15K shares-

1-3 of 3